16-09-19 Intraday BUY LUPIN in cash
only above @ 769.50
forum
LUPIN Share Price Discussion
Lupin Ltd.
Sector: Pharmaceuticals and health care
Sector: Pharmaceuticals and health care
LUPIN Share Price *
768.7 +4.6 (0.6%)
* (quote may be delayed)
LUPIN Discussion Forum
Like
reply
Reply (5)
share
Share
Latest replies
High 770.50 ****
High 771.80 ****
High 772.65 ****
High 774.80 ****
High 778 ****
Lupin gains on approval from Health Canada for hypertension drug
Lupin says it is the first generic company to get an approval for generic Inderal-LA capsules for the Canadian market.
Lupin says it is the first generic company to get an approval for generic Inderal-LA capsules for the Canadian market.
Moneycontrol
Like
reply
Reply
share
Share
Market Headstart: Nifty seen opening higher; HDFC Bank, Castrol top buys
Trends on SGX Nifty indicate a flat to positive opening for the broader index in India, with a 10 points gain or 0.09 percent. Nifty futures were trading around 11,001.50-level on the Singaporean Exchange.
Trends on SGX Nifty indicate a flat to positive opening for the broader index in India, with a 10 points gain or 0.09 percent. Nifty futures were trading around 11,001.50-level on the Singaporean Exchange.
Moneycontrol
Like
reply
Reply
share
Share
2/4calls + 7/8calls booked profit today 50-90% accuracy today in free service...
TCS 1st Target 2365
Lupin 1st Target 765 done
HDFC booked loss SL done
IndusB booked loss SL done
Loss Recovery Calls for Accuracy Maintain
Yes Bank booked profit near at Target 67
Zeel 1st ( 345 ) ...
Read more...
Like
reply
Reply
share
Share
Lupin exploring in-licensing deals to expand neuro-psychiatry, oncology segments
The company is exploring new product offerings for treating multiple sclerosis, migraine, Parkinson's, and Alzheimer's diseases.
The company is exploring new product offerings for treating multiple sclerosis, migraine, Parkinson's, and Alzheimer's diseases.
Moneycontrol
Like
reply
Reply
share
Share
2/4calls + 7/8calls booked profit today 50-90% accuracy today in free service...
TCS 1st Target 2..65
Lupin 1st Target 765 done
HDFC booked loss SL done
IndusB booked loss SL done
Loss Recovery Calls for Accuracy Maintain
Yes Bank booked profit near at Target 67
Zeel 1st ( 445 )...
Read more...
Like
reply
Reply
share
Share
LUPIN GOT US FDA OK FOR GENERIC OF EDECRIN TABLETS
Like
reply
Reply
share
Share
LUPIN daily chart. Cup and handle breakout pattern on the chart.
Like
reply
Reply
share
Share
Lupin Bullish Chart
cmp 773
790 Possible
General View for trading entry exit is important
Like
reply
Reply
share
Share
Lupin gets USFDA nod for chemotherapy-associated nausea and vomiting injection
The company has received approval from the United States Food and Drug Administration (USFDA) for its Fosaprepitant for injection, 150 mg single-dose vial, Lupin said in a statement.
The company has received approval from the United States Food and Drug Administration (USFDA) for its Fosaprepitant for injection, 150 mg single-dose vial, Lupin said in a statement.
Moneycontrol
Like
reply
Reply
share
Share
LUPIN seems weak below 759 for 754,751.9+
Like
reply
Reply
share
Share
Money guru in LUPINBuy Lupin 755
Book profit 765 , this call swing trading
Like
reply
Reply
share
Share
Lupin jumps 2% after Morgan Stanley maintains overweight, sees 32% upside
Lupin entered into a licensing agreement with Germany’s Boehringer Ingelheim to develop and commercialise a novel anti-cancer compound in a deal valued at $700 million.
Lupin entered into a licensing agreement with Germany’s Boehringer Ingelheim to develop and commercialise a novel anti-cancer compound in a deal valued at $700 million.
Moneycontrol
Like
reply
Reply
share
Share
Lupin Ties Up With German Drugmaker Boehringer To Develop, Market Cancer Drugs
The Indian drugmaker said it would receive an upfront payment of $20 million as part of the partnership.
The Indian drugmaker said it would receive an upfront payment of $20 million as part of the partnership.
BloombergQuint
Lupin Ties Up With German Drugmaker Boehringer To Develop, Market Cancer Drugs
Like
reply
Reply
share
Share
BUY LUPIN CASH SEP AT 755 STRICT SL 750 SAFE TRGT 760 FINAL TRGT 764
Like
reply
Reply (1)
share
Share
Latest replies
BOOK PROFIT IN LUPIN CASH AT 758
Nomura On Lupin
Maintain Buy, TP Cut To Rs 913 From Rs 1017
US Has Been Disappointing; Low Expectations Make Risk-reward Favourable
Expect Resolution Of Gavis & Indore/Goa Site In FY21
Mkt Not Factoring In Any Meaningful Upside From Innovation, Biosimilar
Like
reply
Reply
share
Share
MS On Lupin
OW, TP Rs 1003
Co Announced Out-licensing Deal With Boehringher Ingelheim (BI) For Oncology Drugs
Estimate 6-7 Yrs To Commercialise These Assets Assuming Successful Clinical/Regulatory Dvpts
Like
reply
Reply
share
Share
How Lupin's Nagpur facility manages to maintain regulatory compliance
The plant so far had cleared six USFDA inspections with zero observations, including the inspection earlier this month. It was also inspected by UK’s MHRA and WHO, and cleared.
The plant so far had cleared six USFDA inspections with zero observations, including the inspection earlier this month. It was also inspected by UK’s MHRA and WHO, and cleared.
Moneycontrol
Like
reply
Reply
share
Share
*Performance for the WEEK*
*Total notional profits for the WEEK ₹ 3,59,750*
*Futures & Options educational trades for the week 26.8.19 to 30.8.19*
The below trades are given for *educational* purposes and i am not responsible for any losses or profits.
Please note (a) best entry ...
Read more...
Like
reply
Reply
share
Share
Trent: One of the best retail stocks out there
Moneycontrol
Like
reply
Reply
share
Share
Explainer: How Indian pharma companies are riding the biosimilars wave
A Morgan Stanley report says that as many as nine biologic drugs have either gone off patent or will do so by 2025, with combined revenues of $62 billion in 2018.
A Morgan Stanley report says that as many as nine biologic drugs have either gone off patent or will do so by 2025, with combined revenues of $62 billion in 2018.
Moneycontrol
Like
reply
Reply
share
Share
Nearly 30 stocks saw FY20 EPS downgrades in last 4 qtrs; time to exit?
Most brokerage firms have downgraded EPS estimates for Nifty. There are as many as 28 stocks in BSE100 that saw FY20 EPS downgrades in the last four quarters
Most brokerage firms have downgraded EPS estimates for Nifty. There are as many as 28 stocks in BSE100 that saw FY20 EPS downgrades in the last four quarters
Moneycontrol
Like
reply
Reply
share
Share
Market Headstart: Nifty seen opening higher; Axis Bank, D-Mart top buys
Trends on SGX Nifty indicate a positive opening for the broader index in India, with 0.17 percent gain or 19 points. Nifty futures were trading around 11,071-level on the Singaporean Exchange.
Trends on SGX Nifty indicate a positive opening for the broader index in India, with 0.17 percent gain or 19 points. Nifty futures were trading around 11,071-level on the Singaporean Exchange.
Moneycontrol
Like
reply
Reply
share
Share
*Performance on day ONE*
*Futures & Options educational trades for the week 26.8.19 to 30.8.19*
The below trades are given for *educational* purposes and i am not responsible for any losses or profits.
Please note (a) best entry is taken on day 1 (b) the high/low achievement of t...
Read more...
Like
reply
Reply
share
Share
"Lupin subsidiary in South Africa announces Commercial Agreement with Creso Pharmafor hemp oil based cannaQIX??".
Like
reply
Reply
share
Share
Equity commodities in LUPIN15 NOW🚀🚀🚀
15 NOW🚀🚀🚀
Like
reply
Reply
share
Share
Equity commodities in LUPINBuy lupin 750 ce @ 9 Aug exp
15 NOW🚀🚀🚀
Like
reply
Reply
share
Share
UmanathLupin sell @743 SL 751 target 736
Lupin 735 low. Target achieved. If traded put me screenshots in reply corner
Like
reply
Reply
share
Share
*Futures & Options educational trades for the week 26.8.19 to 30.8.19*
The below trades are given for *educational* purposes and i am not responsible for any losses or profits.
Please note (a) best entry is taken on day 1 (b) the high/low achievement of the week is taken for calc...
Read more...
Like
reply
Reply
share
Share
Market Headstart: Nifty likely to open flat; Ashok Leyland, Bank of India top sell ideas
Trends on SGX Nifty indicate a negative opening for the broader index in India, with 0.08 percent loss or 9 points. Nifty futures were trading around 10,716-level on the Singaporean Exchange.
Trends on SGX Nifty indicate a negative opening for the broader index in India, with 0.08 percent loss or 9 points. Nifty futures were trading around 10,716-level on the Singaporean Exchange.
Moneycontrol
Like
reply
Reply
share
Share
Economic Times
Business Standard
Ø India's consumer confidence drops in August: Report
Ø Airtel fastest mobile broadband network, Jio now slowest
Ø Startups with turnover up to Rs 25 cr to get tax break
Ø Gadkari eyes Rs 10L crore revenue from Bharatcraft
Ø Labour code on m...
Read more...
Like
reply
Reply
share
Share
Lupin launches generic antidepressant tablets in US
The product is a generic version of Eli Lilly and Company's Prozac tablets in the same strengths, it added.
The product is a generic version of Eli Lilly and Company's Prozac tablets in the same strengths, it added.
Moneycontrol
Like
reply
Reply
share
Share
rajiv kumar jha in LUPINLupin buy@738 Sl 729 q-100/200
745 👈😁
Like
reply
Reply
share
Share
Lupin to divest its Japanese injectables biz to Neopharma group
"Under the terms of the agreement, Lupin has agreed to sell all the issued and outstanding share capital in Kyowa Criticare Co Ltd to neo ALA Co Ltd. The transaction is subject to customary closing conditions and has been approved by the board of directors of Lupin," Lupin said in a regulatory filing.
"Under the terms of the agreement, Lupin has agreed to sell all the issued and outstanding share capital in Kyowa Criticare Co Ltd to neo ALA Co Ltd. The transaction is subject to customary closing conditions and has been approved by the board of directors of Lupin," Lupin said in a regulatory filing.
Moneycontrol
Like
reply
Reply
share
Share
Lupin gains on sale of Japanese injectables business
The transaction is subject to customary closing conditions and has been approved by the board of directors of Lupin.
The transaction is subject to customary closing conditions and has been approved by the board of directors of Lupin.
Moneycontrol
Like
reply
Reply
share
Share
These 7 'lucky' stocks saw EPS upgrades in last 3 of 4 quarters; time to buy?
Investors should pick those stocks which are displaying signs of consistent growth.
Investors should pick those stocks which are displaying signs of consistent growth.
Moneycontrol
Like
reply
Reply
share
Share
Lupin buy@738
Sl 729 q-100/200
Like
reply
Reply
share
Share
Intraday lupin fut sell 742
Sl-745
Trg-+1/+3/+5🔥🔥🔥😂
Like
reply
Reply (1)
share
Share
Latest replies
All target achieve book profit and exit 🥰🥰😘
Lupin fut buy 740
Sl-729
Trg-745/750/760/765++
Hold 4/6 days🔥🔥🚀
Like
reply
Reply
share
Share
levels in lupin
Level 1 - buy abv 746 for 748 750 752
Level 2 - sell blw 725 for 723 721 719
sl 4 points in both
Like
reply
Reply (1)
share
Share
Latest replies
First trgt achieved 👍👍👍
High made 748.05
1400 profit
Small Traders can book profit or shift sl
Money Market Operations as on February 20, 2014
Money Market Operations as on February 20, 2014
Money Market Operations as on February 20, 2014
moneycontrol.com
Like
reply
Reply
share
Share
Buy Lupin; target of Rs 885: Motilal Oswal
Motilal Oswal is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 885 in its research report dated August 08, 2019.
Motilal Oswal is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 885 in its research report dated August 08, 2019.
www.moneycontrol.com
Like
reply
Reply
share
Share
Surprise or disappointment in Q1: Here’s how top companies have performed this week
Experts say that there is a possibility double-digit earnings growth could be seen after the September quarter
Experts say that there is a possibility double-digit earnings growth could be seen after the September quarter
www.moneycontrol.com
Like
reply
Reply
share
Share
- NewsBotSep 13 9:13 PMLupin gains on approval from Health Canada for hypertension drugMoneycontrolNewsBotSep 13 2:23 PMMarket Headstart: Nifty seen opening higher; HDFC Bank, Castrol top buysMoneycontrolNewsBotSep 12 11:43 PMLupin exploring in-licensing deals to expand neuro-psychiatry, oncology segmentsMoneycontrolNewsBotSep 6 9:38 PMLupin gets USFDA nod for chemotherapy-associated nausea and vomiting injectionMoneycontrolNewsBotSep 5 4:48 PMLupin jumps 2% after Morgan Stanley maintains overweight, sees 32% upsideMoneycontrolNewsBotAug 31 3:53 AMHow Lupin's Nagpur facility manages to maintain regulatory complianceMoneycontrolNewsBotAug 28 3:38 PMTrent: One of the best retail stocks out thereMoneycontrolNewsBotAug 28 2:08 AMExplainer: How Indian pharma companies are riding the biosimilars waveMoneycontrolNewsBotAug 27 3:38 PMNearly 30 stocks saw FY20 EPS downgrades in last 4 qtrs; time to exit?MoneycontrolNewsBotAug 27 2:33 PMMarket Headstart: Nifty seen opening higher; Axis Bank, D-Mart top buysMoneycontrol
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.